Sign Out
Ceftazidime (as pentahydrate)/Avibactam (as sodium) (Zavicefta) is indicated in adults, infants (aged 3 months and older), children and adolescents for the treatment of the following infections (see Precautions and Pharmacology: Pharmacodynamics under Actions): Complicated Intra-Abdominal Infection (cIAI) (in combination with metronidazole); Complicated Urinary Tract Infection, including Pyelonephritis (cUTI); Hospital-acquired Pneumonia (HAP), including Ventilator associated Pneumonia (VAP); Infections due to aerobic Gram-negative organisms in patients with limited treatment options.
Treatment of adult patients with bacteremia that occurs in association with, or is suspected to be associated with cIAI, cUTI, or HAP/VAP.
Consideration should be given to official guidance on the appropriate use of antibacterial agents.
